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After an organised cervical screening programme was introduced in Turin in 1992, the age-adjusted cervical cancer incidence ratio
in 1992–98 was 0.81 (95% confidence interval (CI) 0.59–1.09) for invited vs not invited women and 0.25 (95% CI 0.13–0.50) for
attenders vs non attenders. An organised screening programme can further reduce cervical cancer incidence in an area where
substantial spontaneous activity was previously present.
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There is clear evidence of efficacy for cervical cancer screening
(IARC, 2005). High effectiveness and cost-effectiveness were
obtained in Nordic countries, where cervical screening was
organised from the outset (Laara et al, 1987). In the United
Kingdom, a relevant reduction in cervical cancer mortality
followed reorganisation (Sasieni and Adams, 1999; Peto et al,
2004), There is however little experience of the impact of moving
from opportunistic activity to an organised programme.
For many years, cervical cancer screening in Italy was almost
only opportunistic (Segnan et al, 2000). An organised programme
started in Turin in 1992, the main changes being (a) an active call–
recall system, (b) protocols for diagnosis and treatment, (c) a fail-
safe system for both these phases and (d) monitoring and intensive
quality assurance for every step of the screening process.
In order to evaluate the impact of these changes on invasive
cervical cancer incidence, we linked the screening registry to the
local population cancer registry.
MATERIALS AND METHODS
From June 1992, female Turin inhabitants aged 25–64 years were
invited, irrespective of their previous spontaneous screening
history, for a Pap-test, with 3-year intervals for screen-negatives.
Activation was progressive: in 1996, about 78% of the target
population had been invited and in 1998, about 95%. The order of
invitation was substantially random, with some stratification by
area (women were enrolled by general practitioners, who were
selected with balance by location of practice).
About one-third of invited women attended the organised
programme. Attenders mostly had not had spontaneous recent
cytology. As a combined result of organised and opportunistic
screening, we estimated a 74% 3-year overall coverage (Ronco
et al, 1997) vs 40% before the start of the programme (Segnan et al,
1990).
We computed cervical cancer incidence for women aged 24–69
years in the following groups:
 not invited (not yet having received the first invitation in the
organised programme),
 invited (having already received the first invitation),
 attenders (invited women with at least one cytology in the
organised programme),
 nonattenders (invited women with no cytology in the organised
programme).
Person-years (py) at risk of cervical cancer for the last three
categories were calculated using the computerised screening
registry. It was not possible to consider the screening history
outside the organised programme. Each woman contributed to the
‘invited’ cohort from first invitation to the end of follow-up, that is,
the earliest among (a) diagnosis of cervical cancer, (b) death or
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study). Person-years for attenders were computed from first
cytology within the organised programme to the end of follow-up.
Person-years for uninvited women were computed as difference
between the Turin female population in each calendar year
(estimated on 30 June) and those contributing to the ‘invited’ in
the same year.
Invasive cancers of the uterine cervix diagnosed in Turin
inhabitants from 1992 to the end of 1998 were obtained from
the Piedmont Cancer Registry. Cancers arising in attenders were
further classified as diagnosed after a normal cytology (repeat
recommended after 3 years) or after a non-normal cytology (any
other recommendation, therefore including repeats for unsatisfac-
tory smears).
Cancers reported as microinvasive (FIGO stage 1A1) and those
not classified as squamous cell carcinoma (‘adenocarcinoma’ or
‘other specified morphology’ according to Parkin et al (1998)
(56 cases) were excluded. We included 14 cases with unspecified
morphology to maximise power and reduce possible bias due to
lack of a histological examination or to insufficient reporting, as
both of these could be associated with screening history and their
inclusion prevents bias.
Incidence rates, standardised in 5-year age groups on the world
population (truncated to the 24–69 age), were calculated. Age-
adjusted incidence density ratios (IDR) were computed by Poisson
regression. The proportion of cancers attributable to noninvitation
in the general population, to noncompliance among invited
women and to a screening interval longer than 3.5 years among
women with previous normal cytology was computed from the
above-mentioned age-standardised rates as (Ip–I0)/Ip, where Ip is
the incidence in the entire relevant population (Turin inhabitants,
invited and attenders with ‘negative’ cytology, respectively) and
I0 is the incidence in ‘nonexposed’ women (invited, attenders and
attenders within 3.5 years from a negative cytology, respectively).
RESULTS
Overall, 190 cancers (176 squamous and 14 unspecified) were
included in the analysis. During the study period, 254132 women
received at least one invitation in the organised screening
programme (median follow-up after first invitation 3.9 years).
Among invited women, 762223py (83%) were in the first 3 years
after invitation and only 156639py after the third year.
Incidence among invited and not invited women and, among the
invited, attenders and nonattenders is reported in Table 1. The IDR
was 0.81 (95% CI 0.59–1.09) between invited and uninvited
women and, among the invited, 0.25 (95% CI 0.13–0.50) between
attenders and nonattenders in the organised programme. Some
20% of cancers observed in the study population would have been
avoided if all women were invited and 56% of cancers arising
among invited women would have been avoided if they had all
attended the organised programme.
Among attenders, four cases were diagnosed after a normal
cytology (Table 2): two within 3.5 years (raw incidence rate 0.7 per
10
5) and two after more than 3.5 years (raw incidence 9.0 per 10
5).
Some 65% of cancers observed after negative cytology were
attributable to a screening interval longer than 3.5 years.
Among the seven cancers diagnosed after abnormal cytology
(Table 2), two were identified as a result of screening, all at the first
screening episode. However, five cases arose among women who
did not follow some recommend action (three did not repeat
cytology, one did not have colposcopy and one missed post-
treatment clinical follow-up).
DISCUSSION
In Turin, an organised cervical screening programme was
introduced in a population where some spontaneous screening
was already present. Comparing cervical cancer incidence between
invited and not invited women provides an estimate of its impact,
although underestimated as a result of screening-induced diag-
nostic lead time. This underestimate was partly but not completely
corrected by excluding microinvasive cancers, mainly screen-
detected; therefore, long-term impact, however, would be expected
to be larger. We observed a 20% incidence reduction among
invited vs uninvited women, consistent with our previous estimate
that 17% of coverage among invited women was due to invitation
(Ronco et al, 1997). Available data also suggest that, as an effect of
the organised programme, some of the women who previously had
more frequent spontaneous tests switched to the recommended 3-
year interval (Ronco et al, 1997), resulting in test savings, therefore
plausibly in increased cost-effectiveness.
Table 2 Cervical cancers diagnosed among attenders
Person-years Cancer cases
a Crude incidence (per 10
5py) Age-standardised incidence
b
After non-normal cytology 30973 7 22.6 23.0
After normal cytology
Independently of time 317702 4 1.3 1.2
Within 3.5 years after last normal cytology 295414 2 0.7 0.4
Over 3.5 years after last normal cytology 22288 2 9.0 11.1
aCases with morphology specified as nonsquamous or staged as microinvasive excluded.
bStandardised on the world population truncated 24–69 years, per 100000py.
Table 1 Person-years, number of cervical cancers, incidence density and incidence density ratio (IDR) among not invited and invited women and, within
invited, among attenders and nonattenders
Person-years Cancer cases
a Crude incidence (per 10
5py) Age-standardised incidence
b IDR
c 95% CI
Not invited 1265075 118 9.3 8.6 1.0
Invited 918862 72 7.8 6.9 0.81 0.59–1.09
Invited nonattenders 570186 61 10.7 9.5 1.0
Invited attenders 348676 11 3.2 3.0 0.25 0.13–0.50
aCases with morphology specified as nonsquamous or staged as microinvasive excluded.
bStandardised on the world population truncated 24–69 years, per 100000py.
cAdjusted for age in 5-year groups by Poisson regression.
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countries (IARC, 2005; Antilla et al, 2005). A similar impact can
reasonably be expected in those that would decide to introduce an
organised system.
As the order of invitations was substantially random, risks of
cervical cancer among invited and uninvited women are expected
to be comparable in the absence of screening.
In Denmark, a RR of 0.67 (95% CI, 0.61–0.73) was observed for
women aged 30–59 years in 1963–1982 when comparing counties
with and without organised screening (Lynge et al, 1989).
Attendance in the organised programme was associated with
a more than 70% reduction of cervical cancer incidence. This
is not an estimate of the protection provided by screening in
the organised programme vs no screening at all, as many
nonattenders were screened spontaneously. We had estimated
that about 60% of noncompliers to invitation had had opportu-
nistic cytology within 3 years (Ronco et al, 1997). The observed
reduction is therefore larger than expected, assuming similar
baseline risk among women attending opportunistic and organised
screening and similar protection provided by screening in both
settings. We cannot exclude different baseline risks (higher
detection rate of in situ cervical cancer was found among smears
taken in opportunistic screening in Sweden; Gustafsson et al, 1995)
but our previous data showed that invitation increased coverage,
especially among women with middle–low education (Ronco et al,
1997), who are usually at higher risk. The alternative hypothesis
is that screening in the organised programme was more protective
than opportunistic activity. A greater effectiveness of organised
than spontaneous activity was observed in Finland (Nieminen
et al, 1999).
Excluding nonsquamous cancers, the crude incidence of
invasive cancers within 3.5 years of a normal cytology in the
organised programme (0.7 per 10
5py) was very low. Cytology in
our situation, therefore, showed good sensitivity, perhaps as a
result of the intensive quality assurance programme adopted.
However, it is remarkable that eight cervical adenocarcinomas
arose within 3.5 years from normal cytology, so that with the low
efficacy of cervical screening by cytology in preventing adeno-
carcinoma (IARC, 2005) these were the most common ‘interval’
cancers.
Remarkably, among attenders, five of the 11 cancers occurred in
women who did not follow recommendations. In our population,
the largest overall reduction in cervical cancer incidence would
be obtained by further increasing attendance in the organised
programme and by improving compliance to follow-up. In the UK,
with recommended intervals of 3–5 years and coverage within 5
years exceeding 80%, it was estimated that 23.5% of fully invasive
cancers under the age of 70 years may be attributed to no
screening, 2% to a screening interval over 5 years and 10.5% to
inadequate follow-up (Sasieni et al, 1996).
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